CAS 50-07-7
:Mitomycin C
Description:
Mitomycin C is a potent antitumor antibiotic derived from the bacterium Streptomyces caespitosus. It is classified as an alkylating agent, which means it interferes with DNA synthesis and function, making it effective in treating various cancers, particularly in cases of bladder and gastrointestinal tumors. The compound exhibits a unique mechanism of action by forming cross-links between DNA strands, ultimately leading to cell death. Mitomycin C is typically administered intravenously and is known for its cytotoxic effects, which can result in significant side effects, including myelosuppression, nausea, and potential organ toxicity. Its chemical structure features a quinone moiety, which plays a crucial role in its reactivity and biological activity. Due to its effectiveness, Mitomycin C is often used in combination with other chemotherapeutic agents to enhance therapeutic outcomes. However, careful monitoring is essential during treatment to manage adverse effects and ensure patient safety.
Formula:C15H18N4O5
InChI:InChI=1/C15H18N4O5/c1-5-9(16)12(21)8-6(4-24-14(17)22)15(23-2)13-7(18-13)3-19(15)10(8)11(5)20/h6-7,13,18H,3-4,16H2,1-2H3,(H2,17,22)/t6-,7?,13+,15-/m0/s1
InChI key:InChIKey=NWIBSHFKIJFRCO-WUDYKRTCSA-N
SMILES:O(C)[C@]12N(C3=C([C@H]1COC(N)=O)C(=O)C(N)=C(C)C3=O)C[C@]4([C@@]2(N4)[H])[H]
Synonyms:- (1aS,8S,8aR,8bS)-6-Amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2′,3′:3,4]pyrrolo[1,2-a]indole-4,7-dione
- (6-Amino-8A-Methoxy-5-Methyl-4,7-Dioxo-1,1A,2,4,7,8,8A,8B-Octahydroazireno[2',3':3,4]Pyrrolo[1,2-A]Indol-8-Yl)Methyl Carbamate
- 6-Amino-1,1A,2,8,8A,8B-Hexahydro-8-(Hydroxymethyl)-8A-Methoxy-5-Methylazirino[2',3':3,4]Pyrrolo[1,2-A]Indole-4,7-Dione Carbamate (Ester)
- Ametycine
- Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methyl-, carbamate (ester)
- Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS,8S,8aR,8bS)-
- Azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, [1aS-(1aα,8β,8aα,8bα)]-
- Azirino[2′,3′:3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methoxy-5-methyl-, carbamate (ester)
- Azirino[2′,3′:3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, (1aS,8S,8aR,8bS)-
- Azirino[2′,3′:3,4]pyrrolo[1,2-a]indole-4,7-dione, 6-amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl-, [1aS-(1aα,8β,8aα,8bα)]-
- MMC
- MitoExtra
- Mitocin C
- Mitomicina
- Mitomycin C
- Mitomycin C, Streptomyces caespitosus
- Mitomycine
- Mitonco
- Mitoplus
- Mitozytrex
- Mutamycin
- Mytomycin C
- Mytomycin Kyowa S
- Nsc 26980
- [(1aR,8R,8aS,8bR)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazireno[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate
- [(1aS,8S,8aR,8bS)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazireno[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate
- [(8R,8aS,8bR)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazireno[2',3':3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate
- [1Ar-(1Aalpha,8Beta,8Aalpha,8Balpha)]-6-Amino-8-[[(Aminocarbonyl)Oxy]Methyl]-1,1A,2,8,8A,8B-Hexahydro-8A-Methoxy-5-Methylazirino[2',3':3,4]Pyrrolo[1,2-Alpha]Indole-4,7-Dione
- mitomycin C from streptomyces*caespitosus
- tomycin C
- azirino(2’,3’:3,4)pyrrolo(1,2-a)indole-4,7-dione,6-amino-8-(((aminocarbonyl)oxy
- 8aalpha,8balpha))-(9ci)
- azirino[2’,3’:3,4]pyrrolo[1,2-a]indole-4,7-dione,6-amino-8-[[(aminocarbonyl)ox
- 8balpha)]-8aalph
- azirino(2’,3’:3,4)pyrrolo(1,2-a)indole-4,7-dione,6-amino-1,1a,2,8,8a,8b-hexahy
- mitomycynac
- )methyl)-1,1a,2,8,8a,8b-hexahydro-8-a-methoxy-5-methyl-,(1as-(1aalpha,8beta,
- 7-amino-9-alpha-methoxymitosane
- AMETYCIN
- MITOMYCIN
- mitomycynac(polish)
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 17 products.
Ametycin
CAS:Formula:C15H18N4O5Purity:>98.0%(HPLC)Color and Shape:Dark red to Dark purple to Dark blue powder to crystalMolecular weight:334.33Mitomycin C, 5 mg/ml in DMSO, sterile-filtered
CAS:<p>Mitomycin C, 50-07-7, is an antibiotic and anti-tumor agent which inhibits DNA synthesis by forming DNA crosslinks. Learn more at Thermo Fisher Scientific.</p>Formula:C15H18N4O5Color and Shape:LiquidMolecular weight:334.33Mitomycin
CAS:Antibiotics nesoiFormula:C15H18N4O5Color and Shape:Blue Violet PowderMolecular weight:334.12772Mitomycin C, 4% (with sodium chloride)
CAS:Formula:C15H18N4O5Color and Shape:Grey to blue-purple powderMolecular weight:334.33Mitomycin C
CAS:Formula:C15H18N4O5Purity:(HPLC) ≥ 98.0%Color and Shape:Grey, violet or blue powderMolecular weight:334.33Mitomycin C
CAS:<p>Mitomycin C</p>Formula:C15H18N4O5Purity:By hplc: 99.1% (Typical Value in Batch COA)Color and Shape: blue-violet solidMolecular weight:334.33g/molMitomycin C
CAS:<p>Mitomycin C (Ametycine) is an antineoplastic agent and DNA double-strand crosslinking agent capable of inducing DNA damage, inhibiting DNA synthesis, suppressing mitosis, and activating apoptosis. Mitomycin C is a broad-spectrum antibiotic against both Gram-negative and Gram-positive bacteria.</p>Formula:C15H18N4O5Purity:99.35%Color and Shape:SolidMolecular weight:334.37Mitomycin 100 µg/mL in Acetonitrile
CAS:Controlled ProductFormula:C15H18N4O5Color and Shape:Single SolutionMolecular weight:334.33Mitomycin C
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Mitomycin C is an antitumor antibiotic. It is antineoplastic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Kinoshita, S., et al.: J. Med. Chem., 14, 13 (1971), Beijnen, J.H., et al.: Anal. Profiles Drug Subs., 16, 361 (1986),<br></p>Formula:C15H18N4O5Color and Shape:VioletMolecular weight:334.33Mitomycin C - Bio-X ™
CAS:<p>Mitomycin C is a cytotoxic agent that belongs to the class of mitomycins. It has been used for the treatment of a range of cancers and for ocular surface diseases, such as the glaucoma surgery trabeculectomy. In this case it is administered to reduce post-operative scarring which could otherwise lead to failure of the procedure. Mitomycin C is an alkylating antibiotic that inhibits DNA synthesis by cross-linking the DNA double helix. Mitomycin C also stimulates the production of transforming growth factor β1 (TGF-β1) and basic fibroblast growth factor (bFGF). Clinically, mitomycin can be used both intravenously and topically, and has been studied in a range of wound healing models.</p>Formula:C15H18N4O5Purity:Min. 95%Color and Shape:PowderMolecular weight:334.33 g/molMitomycin C
CAS:<p>Chemoterapeutic agent; DNA crosslinker</p>Formula:C15H18N4O5Purity:Min. 98 Area-%Color and Shape:PowderMolecular weight:334.33 g/molMitomycin C - High Purity
CAS:<p>Mitomycin C is a cytotoxic agent that inhibits DNA synthesis. This product is tested according to USP specification. Mitomycin C has been shown to be effective against resistant mutants and carcinoma cell lines. It also has genotoxic activity and induces statistically significant chromosome aberrations in mammalian cells. Mitomycin C is toxic to the mitochondria, which may be due to its ability to induce mitochondrial membrane potential collapse, leading to apoptosis. Mitomycin C binds to the response element in the genome, causing transcriptional repression of a number of genes involved in cell proliferation, differentiation, or apoptosis. Mitomycin C inhibits squamous carcinoma cells by binding to their DNA and preventing RNA synthesis.</p>Formula:C15H18N4O5Purity:Cas Rn [50-07-7] M. F. C15H18N4O5Color and Shape:PowderMolecular weight:334.33 g/mol













